Condensed Consolidated Balance Sheets - USD ($)	Dec. 31, 2024	Mar. 31, 2024
CURRENT ASSETS
Cash	$ 509,601	$ 786,060
Accounts receivable, net	1,235,867	1,468,655
Inventory [Note 3]	1,570,085	1,879,402
Deposits and other receivables	1,545,790	336,456
Total current assets	4,861,343	4,470,573
Deposits and other receivables [Note 10]	112,972	85,000
Long-term accounts receivable	82,607	149,907
Property and equipment [Note 12]	11,087	15,552
Operating right of use assets [Note 10]	919,394	1,221,593
TOTAL ASSETS	5,987,403	5,942,625
CURRENT LIABILITIES
Accounts payable and accrued liabilities [Note 4]	8,407,458	9,473,118
Convertible promissory notes and short term loans [Note 5]	9,409,106	9,376,471
Term loan, current	2,400,000	2,400,000
Derivative liabilities [Note 8]	412,941	991,866
Operating lease obligations, current [Note 10]	511,922	457,371
Total current liabilities	21,141,427	22,698,826
Federally guaranteed loans [Note 7]	870,800	870,800
Term loan [Note 6]	11,724,476	9,985,033
Derivative liabilities [Note 8]	1,507,271	1,435,668
Operating lease obligations	539,398	929,115
TOTAL LIABILITIES	35,783,372	35,919,442
MEZZANINE EQUITY
Series B Convertible Redeemable preferred stock, $0.001 par value, 600 shares authorized as of December 31, 2024 and March 31, 2024, respectively, 410 and 265 shares issued and outstanding as of December 31, 2024 and March 31, 2024, respectively [Note 9]	2,143,197	1,488,920
STOCKHOLDERS’ DEFICIENCY
Common stock $0.001 par value, 125,000,000 shares authorized as at December 31, 2024, and March 31, 2024, respectively. Issued and outstanding common shares: 24,394,442 and 9,353,768 as at December 31, 2024 and March 31, 2024, respectively, and exchangeable shares of 160,672 outstanding as at December 31, 2024 and March 31, 2024, respectively [Note 9]	24,556	9,515
Shares to be issued 1,005,939 and 324,276 shares of common stock as at December 31, 2024 and March 31, 2024, respectively) [Note 9]	298,543	269,065
Additional paid-in-capital	105,154,121	95,723,083
Accumulated other comprehensive (loss) / income	3,265	32,378
Accumulated deficit	(137,419,652)	(127,499,785)
Total stockholders’ deficiency	(31,939,166)	(31,465,737)
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIENCY	5,987,403	5,942,625
Preferred Stock [Member]
STOCKHOLDERS’ DEFICIENCY
Preferred stock, value	1	1
Series A Preferred Stock [Member]
STOCKHOLDERS’ DEFICIENCY
Preferred stock, value		$ 6